| Home | Triple Ring Advantage | About Us | Our Work | Contact | Careers |
| Triple Ring Technologies and Aubrey Group Announce Strategic Partnership |
| Triple Ring Technologies | Home | Contact |
| Copyright © 2006 - 2008 Triple Ring Technologies, Inc. All Rights Reserved. Triple Ring Technologies is a registered service mark of Triple Ring Technologies, Inc. |
Press Releases
White Papers
PALO ALTO, CA – October 2, 2007 Triple Ring Technologies, a Palo Alto-based provider
of early-stage advanced research and development services, and Aubrey Group, Inc., a
Southern California contract engineering and manufacturing firm specializing in the
development of medical devices, today announced a strategic partnership. This agreement
will allow the two organizations to offer a full range of technology development services from
concept through manufacturing to startup, early-stage, and established medical device and
life sciences companies.
of early-stage advanced research and development services, and Aubrey Group, Inc., a
Southern California contract engineering and manufacturing firm specializing in the
development of medical devices, today announced a strategic partnership. This agreement
will allow the two organizations to offer a full range of technology development services from
concept through manufacturing to startup, early-stage, and established medical device and
life sciences companies.
| Simple Solutions to Complex Technical Problems |
Managing the R&D process for today’s medical device and
life science technologies is no easy feat. Development
projects are increasing in complexity. There is a growing
trend towards the convergence of drugs and devices, and
medical instruments are becoming more sophisticated. At the
same time, investors are placing more stringent demands on
development teams. The standards of due diligence have
been raised, and financings are often completed in milestone-
dependent traunches...
life science technologies is no easy feat. Development
projects are increasing in complexity. There is a growing
trend towards the convergence of drugs and devices, and
medical instruments are becoming more sophisticated. At the
same time, investors are placing more stringent demands on
development teams. The standards of due diligence have
been raised, and financings are often completed in milestone-
dependent traunches...
| We speak your language. All of them. |
The convergence of the biomedical industry with the latest
technological innovations may be the way of the future, but
for those responsible for R&D in biomedical companies, it
makes the present more complicated.
Science and technology, research and development, theory
and applications all must come together, hand-in-hand, to
successfully complete a biomedical device or instrumentation
project. The challenges are both interdisciplinary and
multifaceted, resulting in development projects more
complex than those previously faced by many companies....
technological innovations may be the way of the future, but
for those responsible for R&D in biomedical companies, it
makes the present more complicated.
Science and technology, research and development, theory
and applications all must come together, hand-in-hand, to
successfully complete a biomedical device or instrumentation
project. The challenges are both interdisciplinary and
multifaceted, resulting in development projects more
complex than those previously faced by many companies....
| Innovation. Experience. Collaboration. |
